id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
EPA-R09-OAR-2026-0859-0002,EPA,EPA-R09-OAR-2026-0859,Docket Index - 29 Palms PGF,Other,,2026-02-27T05:00:00Z,2026,2,2026-02-27T05:00:00Z,,2026-02-28T05:39:20Z,,0,0,09000064b91e2f4a
EPA-HQ-OAR-2025-0192-0080,EPA,EPA-HQ-OAR-2025-0192,Memo to Extend the Comment Period,Other,Memorandum to Open a Docket,2026-02-27T05:00:00Z,2026,2,2026-02-27T05:00:00Z,,2026-02-27T23:12:42Z,,0,0,09000064b91e3c47
EPA-R09-OAR-2024-0547-0002,EPA,EPA-R09-OAR-2024-0547,EPA Approval Letter - Big Valley Fuel and Market,Other,,2026-02-27T05:00:00Z,2026,2,2026-02-27T05:00:00Z,,2026-02-28T02:16:29Z,,0,0,09000064b91e2cf7
FDA-2026-H-1921-0001,FDA,FDA-2026-H-1921,Complaint,Other,Complaint,2026-02-27T05:00:00Z,2026,2,2026-02-27T05:00:00Z,,2026-02-27T18:43:51Z,,0,0,09000064b91e2df4
FDA-2007-D-0369-2444,FDA,FDA-2007-D-0369,PSG_020151 - Draft Guidance on Venlafaxine Hydrochloride,Other,Guidance,2026-02-27T05:00:00Z,2026,2,2026-02-27T05:00:00Z,2026-04-29T03:59:59Z,2026-02-27T19:22:37Z,,1,0,09000064b91df4e6
FDA-2007-D-0369-2442,FDA,FDA-2007-D-0369,PSG_020144 - Draft Guidance on Nitroglycerin,Other,Guidance,2026-02-27T05:00:00Z,2026,2,2026-02-27T05:00:00Z,2026-04-29T03:59:59Z,2026-02-27T19:21:57Z,,1,0,09000064b91df4d8
FDA-2007-D-0369-2432,FDA,FDA-2007-D-0369,PSG_018084 - Draft Guidance on Tolmetin Sodium,Other,Guidance,2026-02-27T05:00:00Z,2026,2,2026-02-27T05:00:00Z,2026-04-29T03:59:59Z,2026-02-27T19:18:51Z,,1,0,09000064b91df465
FDA-2007-D-0369-2457,FDA,FDA-2007-D-0369,PSG_021336 - Draft Guidance on Selegiline,Other,Guidance,2026-02-27T05:00:00Z,2026,2,2026-02-27T05:00:00Z,2026-04-29T03:59:59Z,2026-02-27T19:26:39Z,,1,0,09000064b91e011b
FDA-2007-D-0369-2440,FDA,FDA-2007-D-0369,PSG_019982 - Draft Guidance on Bisoprolol Fumarate,Other,Guidance,2026-02-27T05:00:00Z,2026,2,2026-02-27T05:00:00Z,2026-04-29T03:59:59Z,2026-02-27T19:21:21Z,,1,0,09000064b91df4d4
FDA-2007-D-0369-2447,FDA,FDA-2007-D-0369,PSG_020375 - Draft Guidance on Estradiol,Other,Guidance,2026-02-27T05:00:00Z,2026,2,2026-02-27T05:00:00Z,2026-04-29T03:59:59Z,2026-02-27T19:23:38Z,,1,0,09000064b91df4f2
FDA-2007-D-0369-2459,FDA,FDA-2007-D-0369,PSG_021427 - Draft Guidance on Duloxetine Hydrochloride,Other,Guidance,2026-02-27T05:00:00Z,2026,2,2026-02-27T05:00:00Z,2026-04-29T03:59:59Z,2026-02-27T19:27:37Z,,1,0,09000064b91e011f
FDA-2007-D-0369-2461,FDA,FDA-2007-D-0369,PSG_021514 - Draft Guidance on Methylphenidate,Other,Guidance,2026-02-27T05:00:00Z,2026,2,2026-02-27T05:00:00Z,2026-04-29T03:59:59Z,2026-02-27T19:29:28Z,,1,0,09000064b91e0123
FDA-2007-D-0369-2438,FDA,FDA-2007-D-0369,PSG_019813 - Draft Guidance on Fentanyl,Other,Guidance,2026-02-27T05:00:00Z,2026,2,2026-02-27T05:00:00Z,2026-04-29T03:59:59Z,2026-02-27T19:20:47Z,,1,0,09000064b91df4d0
FDA-2007-D-0369-2464,FDA,FDA-2007-D-0369,PSG_021829 - Draft Guidance on Rotigotine,Other,Guidance,2026-02-27T05:00:00Z,2026,2,2026-02-27T05:00:00Z,2026-04-29T03:59:59Z,2026-02-27T19:30:54Z,,1,0,09000064b91e0129
FDA-2007-D-0369-2497,FDA,FDA-2007-D-0369,PSG_213224 - Draft Guidance on Octreotide acetate,Other,Guidance,2026-02-27T05:00:00Z,2026,2,2026-02-27T05:00:00Z,2026-04-29T03:59:59Z,2026-02-27T19:42:17Z,,1,0,09000064b91e018a
FDA-2007-D-0369-2490,FDA,FDA-2007-D-0369,PSG_211843 - Draft Guidance on Tiopronin,Other,Guidance,2026-02-27T05:00:00Z,2026,2,2026-02-27T05:00:00Z,2026-04-29T03:59:59Z,2026-02-27T19:39:55Z,,1,0,09000064b91e0172
FDA-2007-D-0369-2475,FDA,FDA-2007-D-0369,PSG_202211 - Draft Guidance on Oxybutynin,Other,Guidance,2026-02-27T05:00:00Z,2026,2,2026-02-27T05:00:00Z,2026-04-29T03:59:59Z,2026-02-27T19:35:11Z,,1,0,09000064b91e0140
FDA-2007-D-0369-2466,FDA,FDA-2007-D-0369,PSG_022029 - Draft Guidance on Menthol; Methyl Salicylate,Other,Guidance,2026-02-27T05:00:00Z,2026,2,2026-02-27T05:00:00Z,2026-04-29T03:59:59Z,2026-02-27T19:31:54Z,,1,0,09000064b91e012d
FDA-2007-D-0369-2467,FDA,FDA-2007-D-0369,PSG_022083 - Draft Guidance on Rivastigmine,Other,Guidance,2026-02-27T05:00:00Z,2026,2,2026-02-27T05:00:00Z,2026-04-29T03:59:59Z,2026-02-27T19:32:28Z,,1,0,09000064b91e012f
FDA-2007-D-0369-2520,FDA,FDA-2007-D-0369,PSG_218466 - Draft Guidance on Alpelisib,Other,Guidance,2026-02-27T05:00:00Z,2026,2,2026-02-27T05:00:00Z,2026-04-29T03:59:59Z,2026-02-27T19:50:12Z,,1,0,09000064b91e01d3
FDA-2007-D-0369-2511,FDA,FDA-2007-D-0369,PSG_216352 - Draft Guidance on Paliperidone Palmitate,Other,Guidance,2026-02-27T05:00:00Z,2026,2,2026-02-27T05:00:00Z,2026-04-29T03:59:59Z,2026-02-27T19:47:03Z,,1,0,09000064b91e01b4
FDA-2007-D-0369-2512,FDA,FDA-2007-D-0369,PSG_216665 - Draft Guidance on Diazoxide Choline,Other,Guidance,2026-02-27T05:00:00Z,2026,2,2026-02-27T05:00:00Z,2026-04-29T03:59:59Z,2026-02-27T19:47:20Z,,1,0,09000064b91e01b6
FDA-2007-D-0369-2508,FDA,FDA-2007-D-0369,PSG_215431 - Draft Guidance on Meloxicam; Rizatriptan Benzoate,Other,Guidance,2026-02-27T05:00:00Z,2026,2,2026-02-27T05:00:00Z,2026-04-29T03:59:59Z,2026-02-27T19:46:07Z,,1,0,09000064b91e01ad
FDA-2026-H-1656-0001,FDA,FDA-2026-H-1656,Complaint,Other,Complaint,2026-02-27T05:00:00Z,2026,2,2026-02-27T05:00:00Z,,2026-02-27T21:48:13Z,,0,0,09000064b91e2bfb
FDA-2026-H-1788-0001,FDA,FDA-2026-H-1788,Complaint,Other,Complaint,2026-02-27T05:00:00Z,2026,2,2026-02-27T05:00:00Z,,2026-02-27T23:52:17Z,,0,0,09000064b91e385c
FDA-2026-H-1959-0001,FDA,FDA-2026-H-1959,Complaint,Other,Complaint,2026-02-27T05:00:00Z,2026,2,2026-02-27T05:00:00Z,,2026-02-28T00:39:26Z,,0,0,09000064b91e38b5
FDA-2026-H-1963-0001,FDA,FDA-2026-H-1963,Complaint,Other,Complaint,2026-02-27T05:00:00Z,2026,2,2026-02-27T05:00:00Z,,2026-02-28T00:49:16Z,,0,0,09000064b91e30c4
FDA-2026-H-1962-0001,FDA,FDA-2026-H-1962,Complaint,Other,Complaint,2026-02-27T05:00:00Z,2026,2,2026-02-27T05:00:00Z,,2026-02-28T00:45:06Z,,0,0,09000064b91e3dba
FDA-2007-D-0369-2481,FDA,FDA-2007-D-0369,PSG_207620 - Draft Guidance on Sacubitril; Valsartan,Other,Guidance,2026-02-27T05:00:00Z,2026,2,2026-02-27T05:00:00Z,2026-04-29T03:59:59Z,2026-02-27T19:37:17Z,,1,0,09000064b91e0156
FDA-2007-D-0369-2489,FDA,FDA-2007-D-0369,PSG_211733 - Draft Guidance on Acetaminophen; Ibuprofen,Other,Guidance,2026-02-27T05:00:00Z,2026,2,2026-02-27T05:00:00Z,2026-04-29T03:59:59Z,2026-02-27T19:39:39Z,,1,0,09000064b91e0170
FDA-2007-D-0369-2479,FDA,FDA-2007-D-0369,PSG_206089 - Draft Guidance on Testosterone Undecanoate,Other,Guidance,2026-02-27T05:00:00Z,2026,2,2026-02-27T05:00:00Z,2026-04-29T03:59:59Z,2026-02-27T19:36:31Z,,1,0,09000064b91e0152
FDA-2007-D-0369-2469,FDA,FDA-2007-D-0369,PSG_022264 - Draft Guidance on Paliperidone Palmitate,Other,Guidance,2026-02-27T05:00:00Z,2026,2,2026-02-27T05:00:00Z,2026-04-29T03:59:59Z,2026-02-27T19:33:09Z,,1,0,09000064b91e0133
FDA-2007-D-0369-2473,FDA,FDA-2007-D-0369,PSG_085635 - Draft Guidance on Testosterone Cypionate,Other,Guidance,2026-02-27T05:00:00Z,2026,2,2026-02-27T05:00:00Z,2026-04-29T03:59:59Z,2026-02-27T19:34:27Z,,1,0,09000064b91e013c
FDA-2007-D-0369-2488,FDA,FDA-2007-D-0369,PSG_210868 - Draft Guidance on Lorlatinib,Other,Guidance,2026-02-27T05:00:00Z,2026,2,2026-02-27T05:00:00Z,2026-04-29T03:59:59Z,2026-02-27T19:39:21Z,,1,0,09000064b91e016e
FDA-2007-D-0369-2486,FDA,FDA-2007-D-0369,PSG_209310 - Draft Guidance on Mometasone Furoate,Other,Guidance,2026-02-27T05:00:00Z,2026,2,2026-02-27T05:00:00Z,2026-04-29T03:59:59Z,2026-02-27T19:38:46Z,,1,0,09000064b91e016a
FDA-2007-D-0369-2506,FDA,FDA-2007-D-0369,PSG_215401 - Draft Guidance on Dextroamphetamine,Other,Guidance,2026-02-27T05:00:00Z,2026,2,2026-02-27T05:00:00Z,2026-04-29T03:59:59Z,2026-02-27T19:45:23Z,,1,0,09000064b91e01a9
FDA-2007-D-0369-2522,FDA,FDA-2007-D-0369,PSG_218585 - Draft Guidance on Aceclidine Hydrochloride,Other,Guidance,2026-02-27T05:00:00Z,2026,2,2026-02-27T05:00:00Z,2026-04-29T03:59:59Z,2026-02-27T19:51:02Z,,1,0,09000064b91e01d7
FDA-2007-D-0369-2509,FDA,FDA-2007-D-0369,PSG_215602 - Draft Guidance on Baclofen,Other,Guidance,2026-02-27T05:00:00Z,2026,2,2026-02-27T05:00:00Z,2026-04-29T03:59:59Z,2026-02-27T19:46:21Z,,1,0,09000064b91e01af
FDA-2007-D-0369-2516,FDA,FDA-2007-D-0369,PSG_217225 - Draft Guidance on Avacincaptad Pegol Sodium,Other,Guidance,2026-02-27T05:00:00Z,2026,2,2026-02-27T05:00:00Z,2026-04-29T03:59:59Z,2026-02-27T19:48:56Z,,1,0,09000064b91e01cb
FDA-2007-D-0369-2507,FDA,FDA-2007-D-0369,PSG_215429 - Draft Guidance on Venlafaxine Besylate,Other,Guidance,2026-02-27T05:00:00Z,2026,2,2026-02-27T05:00:00Z,2026-04-29T03:59:59Z,2026-02-27T19:45:49Z,,1,0,09000064b91e01ab
FDA-2007-D-0369-2443,FDA,FDA-2007-D-0369,PSG_020145 - Draft Guidance on Nitroglycerin,Other,Guidance,2026-02-27T05:00:00Z,2026,2,2026-02-27T05:00:00Z,2026-04-29T03:59:59Z,2026-02-27T19:22:16Z,,1,0,09000064b91df4da
FDA-2007-D-0369-2460,FDA,FDA-2007-D-0369,PSG_021447 - Draft Guidance on Tizanidine Hydrochloride,Other,Guidance,2026-02-27T05:00:00Z,2026,2,2026-02-27T05:00:00Z,2026-04-29T03:59:59Z,2026-02-27T19:27:59Z,,1,0,09000064b91e0121
FDA-2007-D-0369-2446,FDA,FDA-2007-D-0369,PSG_020357 - Draft Guidance on Metformin Hydrochloride,Other,Guidance,2026-02-27T05:00:00Z,2026,2,2026-02-27T05:00:00Z,2026-04-29T03:59:59Z,2026-02-27T19:23:14Z,,1,0,09000064b91df4f0
FDA-2026-H-1420-0001,FDA,FDA-2026-H-1420,Complaint,Other,Complaint,2026-02-27T05:00:00Z,2026,2,2026-02-27T05:00:00Z,,2026-02-27T23:42:51Z,,0,0,09000064b91e3818
FDA-2007-D-0369-2429,FDA,FDA-2007-D-0369,PSG_012283 - Draft Guidance on Chlorthalidone,Other,Guidance,2026-02-27T05:00:00Z,2026,2,2026-02-27T05:00:00Z,2026-04-29T03:59:59Z,2026-02-27T19:17:46Z,,1,0,09000064b91df45f
FDA-2007-D-0369-2441,FDA,FDA-2007-D-0369,PSG_020076 - Draft Guidance on Nicotine,Other,Guidance,2026-02-27T05:00:00Z,2026,2,2026-02-27T05:00:00Z,2026-04-29T03:59:59Z,2026-02-27T19:21:38Z,,1,0,09000064b91df4d6
FDA-2007-D-0369-2435,FDA,FDA-2007-D-0369,PSG_018891 - Draft Guidance on Clonidine,Other,Guidance,2026-02-27T05:00:00Z,2026,2,2026-02-27T05:00:00Z,2026-04-29T03:59:59Z,2026-02-27T19:19:51Z,,1,0,09000064b91df4ca
FDA-2007-D-0369-2453,FDA,FDA-2007-D-0369,PSG_021180 - Draft Guidance on Ethinyl Estradiol; Norelgestromin,Other,Guidance,2026-02-27T05:00:00Z,2026,2,2026-02-27T05:00:00Z,2026-04-29T03:59:59Z,2026-02-27T19:25:18Z,,1,0,09000064b91e0108
FDA-2007-D-0369-2439,FDA,FDA-2007-D-0369,PSG_019927 - Draft Guidance on Ketoconazole,Other,Guidance,2026-02-27T05:00:00Z,2026,2,2026-02-27T05:00:00Z,2026-04-29T03:59:59Z,2026-02-27T19:21:03Z,,1,0,09000064b91df4d2
FDA-2007-D-0369-2448,FDA,FDA-2007-D-0369,PSG_020489 - Draft Guidance on Testosterone,Other,Guidance,2026-02-27T05:00:00Z,2026,2,2026-02-27T05:00:00Z,2026-04-29T03:59:59Z,2026-02-27T19:23:57Z,,1,0,09000064b91df4f4
FDA-2007-D-0369-2454,FDA,FDA-2007-D-0369,PSG_021234 - Draft Guidance on Diclofenac Epolamine,Other,Guidance,2026-02-27T05:00:00Z,2026,2,2026-02-27T05:00:00Z,2026-04-29T03:59:59Z,2026-02-27T19:25:35Z,,1,0,09000064b91e010a
FDA-2026-H-1922-0001,FDA,FDA-2026-H-1922,Complaint,Other,Complaint,2026-02-27T05:00:00Z,2026,2,2026-02-27T05:00:00Z,,2026-02-27T18:45:55Z,,0,0,09000064b91dfe38
FDA-2007-D-0369-2500,FDA,FDA-2007-D-0369,PSG_214410 - Draft Guidance on Baloxavir Marboxil,Other,Guidance,2026-02-27T05:00:00Z,2026,2,2026-02-27T05:00:00Z,2026-04-29T03:59:59Z,2026-02-27T19:43:31Z,,1,0,09000064b91e0190
FDA-2007-D-0369-2494,FDA,FDA-2007-D-0369,PSG_212516 - Draft Guidance on Duloxetine Hydrochloride,Other,Guidance,2026-02-27T05:00:00Z,2026,2,2026-02-27T05:00:00Z,2026-04-29T03:59:59Z,2026-02-27T19:41:20Z,,1,0,09000064b91e0184
FDA-2007-D-0369-2484,FDA,FDA-2007-D-0369,PSG_208143 - Draft Guidance on Barium Sulfate,Other,Guidance,2026-02-27T05:00:00Z,2026,2,2026-02-27T05:00:00Z,2026-04-29T03:59:59Z,2026-02-27T19:38:13Z,,1,0,09000064b91e015c
FDA-2007-D-0369-2495,FDA,FDA-2007-D-0369,PSG_212526 - Draft Guidance on Alpelisib,Other,Guidance,2026-02-27T05:00:00Z,2026,2,2026-02-27T05:00:00Z,2026-04-29T03:59:59Z,2026-02-27T19:41:39Z,,1,0,09000064b91e0186
FDA-2007-D-0369-2476,FDA,FDA-2007-D-0369,PSG_203479 - Draft Guidance on Clozapine,Other,Guidance,2026-02-27T05:00:00Z,2026,2,2026-02-27T05:00:00Z,2026-04-29T03:59:59Z,2026-02-27T19:35:30Z,,1,0,09000064b91e014c
FDA-2007-D-0369-2482,FDA,FDA-2007-D-0369,PSG_207962 - Draft Guidance on Lidocaine,Other,Guidance,2026-02-27T05:00:00Z,2026,2,2026-02-27T05:00:00Z,2026-04-29T03:59:59Z,2026-02-27T19:37:34Z,,1,0,09000064b91e0158
FDA-2007-D-0369-2523,FDA,FDA-2007-D-0369,PSG_219016 - Draft Guidance on Rilpivirine Hydrochloride,Other,Guidance,2026-02-27T05:00:00Z,2026,2,2026-02-27T05:00:00Z,2026-04-29T03:59:59Z,2026-02-27T19:51:25Z,,1,0,09000064b91e01d9
FDA-2007-D-0369-2514,FDA,FDA-2007-D-0369,PSG_216962 - Draft Guidance on Foscarbidopa; Foslevodopa,Other,Guidance,2026-02-27T05:00:00Z,2026,2,2026-02-27T05:00:00Z,2026-04-29T03:59:59Z,2026-02-27T19:48:20Z,,1,0,09000064b91e01ba
FDA-2007-D-0369-2517,FDA,FDA-2007-D-0369,PSG_217370 - Draft Guidance on Acoltremon,Other,Guidance,2026-02-27T05:00:00Z,2026,2,2026-02-27T05:00:00Z,2026-04-29T03:59:59Z,2026-02-27T19:49:14Z,,1,0,09000064b91e01cd
FDA-2007-D-0369-2515,FDA,FDA-2007-D-0369,PSG_217202 - Draft Guidance on Landiolol Hydrochloride,Other,Guidance,2026-02-27T05:00:00Z,2026,2,2026-02-27T05:00:00Z,2026-04-29T03:59:59Z,2026-02-27T19:48:39Z,,1,0,09000064b91e01bc
FDA-2007-D-0369-2480,FDA,FDA-2007-D-0369,PSG_206968 - Draft Guidance on Acetaminophen,Other,Guidance,2026-02-27T05:00:00Z,2026,2,2026-02-27T05:00:00Z,2026-04-29T03:59:59Z,2026-02-27T19:36:59Z,,1,0,09000064b91e0154
FDA-2026-H-1960-0001,FDA,FDA-2026-H-1960,Complaint,Other,Complaint,2026-02-27T05:00:00Z,2026,2,2026-02-27T05:00:00Z,,2026-02-27T21:40:48Z,,0,0,09000064b91e2fce
FDA-2026-H-1961-0001,FDA,FDA-2026-H-1961,Complaint,Other,Complaint,2026-02-27T05:00:00Z,2026,2,2026-02-27T05:00:00Z,,2026-02-27T22:13:46Z,,0,0,09000064b91e2bfe
FDA-2026-H-1782-0001,FDA,FDA-2026-H-1782,Complaint,Other,Complaint,2026-02-27T05:00:00Z,2026,2,2026-02-27T05:00:00Z,,2026-02-27T23:01:08Z,,0,0,09000064b91e3e15
FDA-2026-H-1785-0001,FDA,FDA-2026-H-1785,Complaint,Other,Complaint,2026-02-27T05:00:00Z,2026,2,2026-02-27T05:00:00Z,,2026-02-27T22:16:22Z,,0,0,09000064b91e37f3
FDA-2026-H-1965-0001,FDA,FDA-2026-H-1965,Complaint,Other,Complaint,2026-02-27T05:00:00Z,2026,2,2026-02-27T05:00:00Z,,2026-02-28T00:10:55Z,,0,0,09000064b91e3d4b
FDA-2026-H-1971-0001,FDA,FDA-2026-H-1971,Complaint,Other,Complaint,2026-02-27T05:00:00Z,2026,2,2026-02-27T05:00:00Z,,2026-02-28T01:24:53Z,,0,0,09000064b91e30c9
FDA-2007-D-0369-2456,FDA,FDA-2007-D-0369,PSG_021306 - Draft Guidance on Buprenorphine,Other,Guidance,2026-02-27T05:00:00Z,2026,2,2026-02-27T05:00:00Z,2026-04-29T03:59:59Z,2026-02-27T19:26:18Z,,1,0,09000064b91e0119
FDA-2026-P-2144-0002,FDA,FDA-2026-P-2144,"Acknowledgement Letter from FDA DMB to Hyman, Phelps & McNamara, P.C.",Other,Acknowledgement Letter/Receipt,2026-02-27T05:00:00Z,2026,2,2026-02-27T05:00:00Z,,2026-02-27T22:06:07Z,,0,0,09000064b91e3859
FDA-1991-N-0191-0002,FDA,FDA-1991-N-0191,Request for Extension from Health Industry Manufacturers Association,Other,Request for Extension,2026-02-27T05:00:00Z,2026,2,2026-02-27T05:00:00Z,,2026-02-28T01:44:11Z,,0,0,090000648052de80
FDA-2026-H-1964-0001,FDA,FDA-2026-H-1964,Complaint,Other,Complaint,2026-02-27T05:00:00Z,2026,2,2026-02-27T05:00:00Z,,2026-02-28T01:59:24Z,,0,0,09000064b91e4522
FDA-2007-D-0369-2492,FDA,FDA-2007-D-0369,PSG_212304 - Draft Guidance on Donepezil Hydrochloride,Other,Guidance,2026-02-27T05:00:00Z,2026,2,2026-02-27T05:00:00Z,2026-04-29T03:59:59Z,2026-02-27T19:40:33Z,,1,0,09000064b91e0180
FDA-2007-D-0369-2503,FDA,FDA-2007-D-0369,PSG_215039 - Draft Guidance on Alpelisib,Other,Guidance,2026-02-27T05:00:00Z,2026,2,2026-02-27T05:00:00Z,2026-04-29T03:59:59Z,2026-02-27T19:44:36Z,,1,0,09000064b91e0196
FDA-2007-D-0369-2493,FDA,FDA-2007-D-0369,PSG_212306 - Draft Guidance on Selinexor,Other,Guidance,2026-02-27T05:00:00Z,2026,2,2026-02-27T05:00:00Z,2026-04-29T03:59:59Z,2026-02-27T19:40:55Z,,1,0,09000064b91e0182
FDA-2007-D-0369-2498,FDA,FDA-2007-D-0369,PSG_213953 - Draft Guidance on Testosterone Undecanoate,Other,Guidance,2026-02-27T05:00:00Z,2026,2,2026-02-27T05:00:00Z,2026-04-29T03:59:59Z,2026-02-27T19:42:31Z,,1,0,09000064b91e018c
FDA-2007-D-0369-2472,FDA,FDA-2007-D-0369,PSG_050440 - Draft Guidance on Cephalexin,Other,Guidance,2026-02-27T05:00:00Z,2026,2,2026-02-27T05:00:00Z,2026-04-29T03:59:59Z,2026-02-27T19:34:04Z,,1,0,09000064b91e013a
FDA-2007-D-0369-2485,FDA,FDA-2007-D-0369,PSG_208171 - Draft Guidance on Ferric Derisomaltose,Other,Guidance,2026-02-27T05:00:00Z,2026,2,2026-02-27T05:00:00Z,2026-04-29T03:59:59Z,2026-02-27T19:38:28Z,,1,0,09000064b91e015e
FDA-2007-D-0369-2501,FDA,FDA-2007-D-0369,PSG_214522 - Draft Guidance on Tadalafil,Other,Guidance,2026-02-27T05:00:00Z,2026,2,2026-02-27T05:00:00Z,2026-04-29T03:59:59Z,2026-02-27T19:44:01Z,,1,0,09000064b91e0192
FDA-2007-D-0369-2491,FDA,FDA-2007-D-0369,PSG_212268 - Draft Guidance on Asenapine,Other,Guidance,2026-02-27T05:00:00Z,2026,2,2026-02-27T05:00:00Z,2026-04-29T03:59:59Z,2026-02-27T19:40:16Z,,1,0,09000064b91e017e
FDA-2007-D-0369-2477,FDA,FDA-2007-D-0369,PSG_204017 - Draft Guidance on Ethinyl Estradiol; Levonorgestrel,Other,Guidance,2026-02-27T05:00:00Z,2026,2,2026-02-27T05:00:00Z,2026-04-29T03:59:59Z,2026-02-27T19:35:51Z,,1,0,09000064b91e014e
FDA-2007-D-0369-2496,FDA,FDA-2007-D-0369,PSG_213004 - Draft Guidance on Amoxicillin; Omeprazole Magnesium; Rifabutin,Other,Guidance,2026-02-27T05:00:00Z,2026,2,2026-02-27T05:00:00Z,2026-04-29T03:59:59Z,2026-02-27T19:41:55Z,,1,0,09000064b91e0188
FDA-2007-D-0369-2434,FDA,FDA-2007-D-0369,PSG_018859 - Draft Guidance on Ribavirin,Other,Guidance,2026-02-27T05:00:00Z,2026,2,2026-02-27T05:00:00Z,2026-04-29T03:59:59Z,2026-02-27T19:19:33Z,,1,0,09000064b91df4c8
FDA-2007-D-0369-2431,FDA,FDA-2007-D-0369,PSG_017874 - Draft Guidance on Scopolamine,Other,Guidance,2026-02-27T05:00:00Z,2026,2,2026-02-27T05:00:00Z,2026-04-29T03:59:59Z,2026-02-27T19:18:30Z,,1,0,09000064b91df463
FDA-2007-D-0369-2449,FDA,FDA-2007-D-0369,PSG_020538 - Draft Guidance on Estradiol,Other,Guidance,2026-02-27T05:00:00Z,2026,2,2026-02-27T05:00:00Z,2026-04-29T03:59:59Z,2026-02-27T19:24:10Z,,1,0,09000064b91df4f6
FDA-2007-D-0369-2462,FDA,FDA-2007-D-0369,PSG_021588 - Draft Guidance on Imatinib Mesylate,Other,Guidance,2026-02-27T05:00:00Z,2026,2,2026-02-27T05:00:00Z,2026-04-29T03:59:59Z,2026-02-27T19:29:47Z,,1,0,09000064b91e0125
FDA-2007-D-0369-2513,FDA,FDA-2007-D-0369,PSG_216675 - Draft Guidance on Perfluorohexyloctane,Other,Guidance,2026-02-27T05:00:00Z,2026,2,2026-02-27T05:00:00Z,2026-04-29T03:59:59Z,2026-02-27T19:47:39Z,,1,0,09000064b91e01b8
FDA-2007-D-0369-2510,FDA,FDA-2007-D-0369,PSG_216318 - Draft Guidance on Testosterone Cypionate,Other,Guidance,2026-02-27T05:00:00Z,2026,2,2026-02-27T05:00:00Z,2026-04-29T03:59:59Z,2026-02-27T19:46:43Z,,1,0,09000064b91e01b1
FDA-2007-D-0369-2458,FDA,FDA-2007-D-0369,PSG_021351 - Draft Guidance on Oxybutynin,Other,Guidance,2026-02-27T05:00:00Z,2026,2,2026-02-27T05:00:00Z,2026-04-29T03:59:59Z,2026-02-27T19:27:00Z,,1,0,09000064b91e011d
FDA-2026-P-1300-0005,FDA,FDA-2026-P-1300,Suitability Petition Amendment from APDM Pharmaceuticals Private Limited,Other,Amendment,2026-02-27T05:00:00Z,2026,2,2026-02-27T05:00:00Z,,2026-02-27T23:32:34Z,,1,0,09000064b91e3c62
FDA-2026-P-2144-0001,FDA,FDA-2026-P-2144,"Suitability Petition from Hyman, Phelps & McNamara, P.C.",Other,Petition(s),2026-02-27T05:00:00Z,2026,2,2026-02-27T05:00:00Z,,2026-02-27T22:05:51Z,,1,0,09000064b91e3853
FDA-2026-H-1786-0001,FDA,FDA-2026-H-1786,Complaint,Other,Complaint,2026-02-27T05:00:00Z,2026,2,2026-02-27T05:00:00Z,,2026-02-27T22:57:13Z,,0,0,09000064b91e30c0
FDA-2026-H-1958-0001,FDA,FDA-2026-H-1958,Complaint,Other,Complaint,2026-02-27T05:00:00Z,2026,2,2026-02-27T05:00:00Z,,2026-02-27T23:55:07Z,,0,0,09000064b91e3874
FDA-2026-H-1968-0001,FDA,FDA-2026-H-1968,Complaint,Other,Complaint,2026-02-27T05:00:00Z,2026,2,2026-02-27T05:00:00Z,,2026-02-28T01:29:56Z,,0,0,09000064b91e451e
FDA-2026-H-1972-0001,FDA,FDA-2026-H-1972,Complaint,Other,Complaint,2026-02-27T05:00:00Z,2026,2,2026-02-27T05:00:00Z,,2026-02-28T01:27:00Z,,0,0,09000064b91e451b
FDA-2007-D-0369-2436,FDA,FDA-2007-D-0369,PSG_019081 - Draft Guidance on Estradiol,Other,Guidance,2026-02-27T05:00:00Z,2026,2,2026-02-27T05:00:00Z,2026-04-29T03:59:59Z,2026-02-27T19:20:10Z,,1,0,09000064b91df4cc
FDA-2007-D-0369-2455,FDA,FDA-2007-D-0369,PSG_021258 - Draft Guidance on Estradiol; Levonorgestrel,Other,Guidance,2026-02-27T05:00:00Z,2026,2,2026-02-27T05:00:00Z,2026-04-29T03:59:59Z,2026-02-27T19:25:50Z,,1,0,09000064b91e010c
FDA-2007-D-0369-2451,FDA,FDA-2007-D-0369,PSG_020831 - Draft Guidance on Formoterol Fumarate,Other,Guidance,2026-02-27T05:00:00Z,2026,2,2026-02-27T05:00:00Z,2026-04-29T03:59:59Z,2026-02-27T19:24:44Z,,1,0,09000064b91e0104
FDA-2007-D-0369-2450,FDA,FDA-2007-D-0369,PSG_020612 - Draft Guidance on Lidocaine,Other,Guidance,2026-02-27T05:00:00Z,2026,2,2026-02-27T05:00:00Z,2026-04-29T03:59:59Z,2026-02-27T19:24:27Z,,1,0,09000064b91df4f8